Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1097/01.ccm.0000220765.22184.ed | Reliability and validity of the Pediatric Intensity Level of Therapy (PILOT) scale: A measure of the use of intracranial pressure–directed therapies |
| https://doi.org/10.1002/chp.20087 | A case study in experiential learning: Pharmaceutical cold chain management on wheels * |
| https://doi.org/10.1007/b104242 | Types of Filtration |
| https://doi.org/10.5731/pdajpst.2018.008771 | The Impact of Quality Culture on Operational Performance—An Empirical Study from the Pharmaceutical Industry |
| https://doi.org/10.1016/j.xphs.2024.08.018 | Is access to leadership roles contributing to the gender pay gap in the pharmaceutical sciences? |
| https://doi.org/10.1331/japha.2009.08140 | Integration of temperature-controlled requirements into pharmacy practice |
| https://doi.org/10.5731/pdajpst.2015.01078 | Quality Culture Survey Report |
| https://doi.org/10.5731/pdajpst.2018.009027 | Achieving “Zero” Defects for Visible Particles in Injectables |
| https://doi.org/10.5731/pdajpst.2014.00954 | A Risk-Based Auditing Process for Pharmaceutical Manufacturers |
| An interpretation of the pharmaceutical industry survey of current sterile filtration practices. | |
| https://doi.org/10.1007/bf01183840 | B-spline FIR filters |
| U.S. v. Barr Laboratories: a technical perspective. | |
| https://doi.org/10.5731/pdajpst.2015.01053 | Proceedings of the 2013 Viral Clearance Symposium (Princeton, NJ) |
| Regulatory aspects of isolation/barrier technology. | |
| https://doi.org/10.5731/pdajpst.2019.010645 | Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations |
| https://doi.org/10.5731/pdajpst.2016.006874 | Introduction: Proceedings of the 2015 Viral Clearance Symposium |
| Carleton's corner. Should the United States pharmacopeia define manufacturing process limits? | |
| https://doi.org/10.5731/pdajpst.2014.00957 | Proceedings of the 2011 Viral Clearance Symposium (South San Francisco, CA) |
| PDA comments to USP on 'proposed changes to <71> sterility tests'. | |
| https://doi.org/10.5731/pdajpst.2019.001118 | PDA Responds to the Novel Coronavirus Situation |
| https://doi.org/10.5731/pdajpst.2012.00885 | Pre-use/Post-sterilization Integrity Testing of Sterilizing Grade Filters |
| https://doi.org/10.5731/pdajpst.2015.01048 | PDA Single-Use Systems Cross-Organizational Workshop--Meeting Summary, May 14, 2014--PDA Global Headquarters, Bethesda, MD |
| https://doi.org/10.1002/qaj.220 | The International Association for Pharmaceutical Science and Technology |
| Be careful who and what you are recording. | |
| Dr. Jon J. Johnston, incoming president, Addresses PDA House of Delegates. | |
| https://doi.org/10.5731/pdajpst.2018.001109 | Special Viral Clearance Issue and St Gallen PDA Collaboration Paper |
| https://doi.org/10.5731/pdajpst.2019.001115 | PDA JPST Online Reboot |
| What they did not teach you in dental school. |